Debut Plus

₹271.58

▲ +0.19 +0.07%

16 Jul 2026

NSE Listed

Nureca Limited (NURECA)

Volume: 85,935Avg Vol 1W: 1,27,567Avg Vol 1M: 43,034.752W Range:₹204₹343
NSE BSE www.nureca.com
Key Ratios
Checked 15h ago
Market Cap₹259 Cr
Current Price₹271.58
Previous Close₹271.39
High / Low (52w)₹343 / ₹204
Volume85,935
Avg Vol (1W)1,27,567
Avg Vol (1M)43,034.7
Stock P/E—
Book Value₹189.48
Dividend Yield0%
ROE1.2%
ROA1.1%
Revenue (TTM)₹122 Cr
Revenue Growth19.3%
Profit Margin1.4%
Total Debt₹1 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹-6.45
P/B1.43
Debt / Equity0.01
50 DMA₹245.66
200 DMA₹266.75
Day change+0.07%
Price Chart
₹271.58▲ 4.39% · 1Y
₹333₹20710.6L
2025-07-16
2026-07-15

20-day avg volume: 43K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 38% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹20 Cr₹31 Cr₹26 Cr₹32 Cr₹34 Cr₹38 Cr₹40 Cr₹35 Cr
EBITDA₹3 Cr₹0 Cr₹-3 Cr₹3 Cr₹1 Cr₹5 Cr₹5 Cr₹-5 Cr
Net Profit₹2 Cr₹0 Cr₹-3 Cr₹2 Cr₹1 Cr₹4 Cr₹4 Cr₹-6 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹62 Cr₹99 Cr₹216 Cr₹263 Cr₹118 Cr₹102 Cr₹122 Cr
EBITDA₹9 Cr₹9 Cr₹64 Cr₹62 Cr₹-10 Cr₹-2 Cr₹3 Cr
Net Profit₹6 Cr₹6 Cr₹46 Cr₹45 Cr₹-8 Cr₹-2 Cr₹1 Cr
EPS8.899.1462.0444.96-8.25-1.790.85
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹24 Cr₹34 Cr₹186 Cr₹219 Cr₹207 Cr₹205 Cr₹210 Cr
Total Liabilities₹16 Cr₹19 Cr₹23 Cr₹16 Cr₹12 Cr₹12 Cr₹16 Cr
Equity₹8 Cr₹15 Cr₹163 Cr₹203 Cr₹195 Cr₹193 Cr₹194 Cr
Total Debt———————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹-8 Cr₹50 Cr₹19 Cr₹14 Cr₹-4 Cr₹-18 Cr₹3 Cr
Investing₹0 Cr₹0 Cr₹-110 Cr₹-3 Cr₹-16 Cr₹18 Cr₹8 Cr₹14 Cr
Financing₹0 Cr₹8 Cr₹92 Cr₹-7 Cr₹-2 Cr₹-1 Cr₹0 Cr₹-20 Cr
Free Cash Flow₹0 Cr₹-8 Cr₹50 Cr₹19 Cr₹14 Cr₹-4 Cr₹-18 Cr₹3 Cr
Shareholding
Promoter 68.09% Institutions 0.51% Public 31.39%
Efficiency & Working Capital
ROCE3.4%
Interest Coverage4.9
Dividend Payout—
Debtor Days19 d
Inventory Days118 d
Payable Days13 d
Cash Conversion Cycle125 d
Working Capital Days137 d
Shareholding Details

As of 2026-03-31

Promoter68.1%
FII0.3%
DII0.2%
Institutions0.5%
Public31.4%
Promoter Pledge0%
No. of Shareholders34,558
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Jan 2026Jan 2026Mar 2026
Promoters63.2%63.2%63.2%63.8%64.1%64.3%64.3%65%65%68.1%68.1%68.1%
FIIs0.1%0.1%0.1%0.7%0.4%1.1%0.1%0.1%0.1%0.1%0.1%0.3%
DIIs0%0%0%0%0%0%0%0%0%0%0%0.2%
Public36.7%36.7%36.7%35.5%35.5%34.6%35.6%34.9%34.9%31.8%31.8%31.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders49,60045,99643,81341,98641,31439,30438,07537,46835,80135,80035,80034,558
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Saurabh GoyalShareholding of Promoter and Promoter Group33.7%32,17,214
Payal GoyalShareholding of Promoter and Promoter Group21.6%20,59,928
Aryan GoyalShareholding of Promoter and Promoter Group12.2%11,59,185
Nectar Biopharma Private LimitedShareholding of Promoter and Promoter Group0.6%60,842
Smita GoyalShareholding of Promoter and Promoter Group0%7
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Saurabh Goyal00%2026-03-31
Payal Goyal00%2026-03-31
Smita Goyal00%2026-03-31
Aryan Goyal00%2026-03-31
Nectar Biopharma Private Limited00%2026-03-31
Saurabh Goyal00%2026-01-07
Payal Goyal00%2026-01-07
Smita Goyal00%2026-01-07
Aryan Goyal00%2026-01-07
Nectar Biopharma Private Limited00%2026-01-07
Saurabh Goyal00%2025-12-31
Payal Goyal00%2025-12-31
Board of Directors
NameDesignationYear
Saurabh GoyalChairman & Managing Director2025
Vijay Kumar SharmaIndependent Director2025
Charu SinghIndependent Director2025
Ruchita AgarwalIndependent Director2025
Aryan GoyalWhole Time Director & Chief Executive Officer2025
Rajinder SharmaWhole-time Director2025
Rupinder TewariIndependent Director2025
Kuldip Kumar BhasinIndependent Director2025
Nishu KansalCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Home Healthcare and Wellness Produc₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹147 Cr99.9%
Outside India₹0 Cr0.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10111010
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-21Board Meetings—
buyback2025-12-24₹330 max—
forthcoming—Book ClosureAGM
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025390011051
202511000011
2025000000
Insider / Designated-Person Trades

18 recent disclosure(s)

Nectar Biopharma Private LimitedDisposal · 60,842
Saurabh GoyalAcquisition · 60,842
VIVEK GUPTAAcquisition · 945
SAURABH GOYALAcquisition · 6,104
VIVEK GUPTAAcquisition · 950
ARYAN GOYAL RevisedAcquisition · 5,321
Company Information
Incorporated2016
ChairmanSaurabh Goyal
AuditorSinghi & Co
Investor Email[email protected]
🌐 www.nureca.com ↗

📍 101 Gala Number Udyog Bhavan, I Flr Sonawala Lane Goregaon(E, Mumbai, Maharashtra, 400063

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

N R Vandana Tex Ind Ltd.Nalwa Sons Investment Ltd.NMDC Steel LimitedNTPC Ltd.NTPC Green Energy LimitedNucleus Software ExportsNuvama Wealth Manage Ltd.Nuvoco Vistas Corp Ltd.Nexus Select TrustNxt-Infra TrustFsn E Commerce VenturesOriental Aromatics Ltd.All “N” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search